1) efficacy enhancing and toxicity reducing
增效减毒
1.
Clinical study on effect of aidi Injection in efficacy enhancing and toxicity reducing of radiotherapy and chemotherapy in patients of malignant tumor;
艾迪注射液在恶性肿瘤放、化疗中增效减毒作用的临床研究
2.
Objective: To observe the effect of Astragalus membranaceus efficacy enhancing and toxicity reducing on chemotherapy in patients of malignant tumor.
目的:观察黄芪在恶性肿瘤化疗中的增效减毒作用。
3.
Objective:To study the chemical therapeutic effects and efficacy enhancing and toxicity reducing of GAPSGF injection on mice who are treated with chemical therapeutic drug like Cytoxan.
目的:探讨树舌多糖GF注射液对化疗药物环磷酰胺的增效减毒作用及其作用机制。
2) synergy and attenuation
增效减毒
1.
Experimental study on synergy and attenuation of Dangguibuxue Decoction to 5-fluorouridine;
当归补血汤对化疗药物5-Fu增效减毒的实验研究
2.
Synergy and Attenuation of Cyclophosphamidum(CTX) Activities by LiuJunZi Decoction;
六君子汤对环磷酰胺的增效减毒作用研究
3) toxicity reducing and efficacy enhancing
减毒增效
1.
Objective: To observe the effect of Shanxian granule(SXG) and Chemotherapy in toxicity reducing and efficacy enhancing in patients with with digestion tract cancer.
目的观察山仙颗粒联合化疗治疗消化道癌的减毒增效作用。
2.
Objective: To study the effect of composite Shenqi Pill (CSQP) in toxicity reducing and efficacy enhancing on chemo and radio therapy in patients with lung cancer.
目的 :研究复方参芪丸对肺癌患者在化放疗过程中的减毒增效作用。
4) attenuation and synergy
减毒增效
1.
Advances in studies compatibility applied toattenuation and synergy of Tripterygium wilfordii;
中药配伍应用于雷公藤减毒增效的研究进展
2.
Clinical Effect Observation of the Attenuation and Synergy with the Prescription of Gu Ai Tong Tai;
骨癌通泰方对恶性骨肿瘤化疗减毒增效作用研究
5) attenuation and synergistic effect
减毒增效
1.
[Objective] To observe the attenuation and synergistic effect of combined double Oxygen-Vanadium(α-Furoic Acid,VO-FA) and Liuwei Rehmaniae Bolus(LWRB) in rats with diabetes mellitus(DM).
[目的]观察双(α-呋喃甲酸)氧钒(VO-FA)与六味地黄丸联合使用对糖尿病大鼠减毒增效的作用。
6) toxicity reducing and effect enhancing
增效及减毒
补充资料：一增一减
【一增一减】
（术语）经劫之间人寿一增一减也。俱舍论光记十二曰：“增减者，从人寿十岁，增至八万岁，复从八万岁，减至十岁。”此一增一减之间，新译家称曰中劫。俱舍论十二曰：“此洲人寿经无量时，至住劫初，寿方渐减。从无量减，至极十年，即名为初一住中劫。此后十八，皆有增减。谓从十年增至八万，复从八万减至十年，尔乃名为第二中劫。次后十七，例皆如是。于十八后，从十岁增，极至八万岁，名第二中劫。”旧译家名此一增一减曰小劫。佛祖统纪三十曰：“如是一减一增，为一小劫，二十增减为一中劫。”
（术语）经劫之间人寿一增一减也。俱舍论光记十二曰：“增减者，从人寿十岁，增至八万岁，复从八万岁，减至十岁。”此一增一减之间，新译家称曰中劫。俱舍论十二曰：“此洲人寿经无量时，至住劫初，寿方渐减。从无量减，至极十年，即名为初一住中劫。此后十八，皆有增减。谓从十年增至八万，复从八万减至十年，尔乃名为第二中劫。次后十七，例皆如是。于十八后，从十岁增，极至八万岁，名第二中劫。”旧译家名此一增一减曰小劫。佛祖统纪三十曰：“如是一减一增，为一小劫，二十增减为一中劫。”
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条